F.D.A. Panel Rejects Drug for Obesity
The French drug company Sanofi-aventis announced on Wednesday that a Food and Drug Administration advisory panel has voted unanimously not to recommend approving its new weight loss drug, citing concerns about...To view the full article, register now.
Already a subscriber? Click here to view full article